Phase 3 PANOVA-3 study: Tumor treating fields (TTFields) therapy concomitant with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic cancer.

被引：0
|
作者：
Babiker, Hani M.
Macarulla, Teresa
Philip, Agop Philip
Becerra, Carlos Roberto
Dragovich, Tomislav
Picozzi, Vincent J.
机构：
[1] Mayo Clin Florida, Jacksonville, FL USA
[2] Vall Hebron Univ Hosp, Vall Hebron Inst Oncol VHIO, Barcelona, Spain
[3] Karmanos Canc Inst, Detroit, MI USA
[4] Hoag Family Canc Inst, Newport Beach, CA USA
[5] Banner MD Anderson Canc Ctr, Gilbert, AZ USA
[6] Virginia Mason Hosp & Med Ctr, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4199
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer.
    Mahipal, Amit
    Springett, Gregory M.
    Burke, Nancy
    Bertels, Barbara
    Wapinsky, Georgine
    Almhanna, Khaldoun
    Kim, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [32] Phase 1b study of gemcitabine, nab-paclitaxel, and ficlatuzumab in patients with advanced pancreatic cancer.
    Perez, Kimberly
    Rubinson, Douglas Adam
    Cleary, James M.
    Meyerhardt, Jeffrey A.
    Patel, Anuj K.
    Abrams, Thomas Adam
    Rahma, Osama E.
    Raghavan, Srivatsan
    Aguirre, Andrew
    Needle, Michael N.
    Das, Koushik
    Pitarresi, Jason
    Bakir, Basil
    Rustgi, Anil K.
    Wolpin, Brian M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Sindilimab combined with nab-paclitaxel plus gemcitabine as first-line treatment for patients with advanced pancreatic cancer.
    Zhu, Huayun
    Sun, Xiaofeng
    Pan, Xuan
    Wu, Pingping
    Chen, Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
    Suguru Yamada
    Tsutomu Fujii
    Yukihiro Yokoyama
    Hiroki Kawashima
    Osamu Maeda
    Kojiro Suzuki
    Tohru Okada
    Eizaburo Ono
    Junpei Yamaguchi
    Nao Takano
    Hideki Takami
    Masamichi Hayashi
    Yukiko Niwa
    Yoshiki Hirooka
    Yoshiyuki Ito
    Shinji Naganawa
    Yuichi Ando
    Masato Nagino
    Hidemi Goto
    Yasuhiro Kodera
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 815 - 821
  • [35] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
    Yamada, Suguru
    Fujii, Tsutomu
    Yokoyama, Yukihiro
    Kawashima, Hiroki
    Maeda, Osamu
    Suzuki, Kojiro
    Okada, Tohru
    Ono, Eizaburo
    Yamaguchi, Junpei
    Takano, Nao
    Takami, Hideki
    Hayashi, Masamichi
    Niwa, Yukiko
    Hirooka, Yoshiki
    Ito, Yoshiyuki
    Naganawa, Shinji
    Ando, Yuichi
    Nagino, Masato
    Goto, Hidemi
    Kodera, Yasuhiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (05) : 815 - 821
  • [36] PANOVA: a phase II study of TTFields (150 kHz) with concomitant standard chemotherapy for front-line advanced pancreatic adenocarcinoma: Updated efficacy results
    Kueng, M.
    Guillen-Ponce, C.
    Rivera Herrero, F.
    J., Gallego Plazas
    Lopez-Martin, J. A.
    Benavides, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [37] PANOVA-4 (EF-39): Pilot study of tumor treating fields (TTFields) therapy with atezolizumab, gemcitabine (GEM), and nab-paclitaxel (NabP) as first-line (1L) treatment for metastatic pancreatic ductal adenocarcinoma (mPDAC).
    Seufferlein, Thomas
    Gracian, Antonio Cubillo
    Kueng, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS718 - TPS718
  • [38] A phase Ib study evaluating olaratumab in combination with nab-paclitaxel and gemcitabine in first-line treatment of metastatic pancreatic cancer.
    Pelzer, Uwe
    Bendell, Johanna C.
    Womack, Mark S.
    Bahary, Nathan
    Macarulla, Teresa
    Borazanci, Erkut Hasan
    Levy, Donna Elise
    Mo, Gary
    Ramage, Samuel Cowan
    Garrido-Laguna, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [39] PANOVA: A phase II study of TTFields (150kHz) concomitant with standard chemotherapy for front line therapy of advanced pancreatic adenocarcinoma
    Benavides, Manuel
    Guillen, Carmen
    Rivera, Fernando
    Gallego, Javier
    Lopez-Martin, Jose
    Kung, Marc
    CANCER RESEARCH, 2017, 77
  • [40] The Phase 1 Study of Concurrent Chemoradiation Therapy With Gemcitabine and Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Adenocarcinoma Patients
    Ioka, T.
    Katayama, K.
    Takada, R.
    Fukutake, N.
    Ohkawa, K.
    Akita, H.
    Takahashi, H.
    Konishi, K.
    Teshima, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S205 - S205
12345